Jump to content
helplinedonate
  • Announcements

    • ForumAdmin

      Frequently Asked Questions - Step by step guides

      Do you need assistance registering, logging in, posting, etc? Please visit the all new Frequently Asked Question Forum for step-by-step guides. Click the link below to access these helpful guides. Frequently Asked Questions
    • ForumAdmin

      Recursos Nuevos en Español

      http://www.parkinson.org/ayuda   http://www.parkinson.org/espanol    
    • ForumAdmin

      Línea de Ayuda 1-800-473-4636

      Línea de Ayuda 1-800-473-4636   ¿Qué es la línea de ayuda 1-800-4PD-INFO (473-4636) de la Fundación Nacional de Parkinson? Es un número de teléfono gratuito que ayuda a las personas con la enfermedad de Parkinson, sus familiares, amigos y profesionales de salud, a solucionar diferentes inquietudes.   La línea de ayuda ofrece: Información actualizada Apoyo emocional Referidos a profesionales de salud Recursos comunitarios Amplia variedad de publicaciones gratis    

Search the Community

Showing results for tags 'Years to wait though'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Forum Information
    • Discussion Corner Announcements
    • PF Forum Member Service Center
    • Frequently Asked Questions - How Do I...???
  • Medical Questions
    • Ask The Doctor
    • Ask The Surgical Team
    • Ask about Nutrition
    • Ask the Pharmacist
    • Pregúntele al Médico
    • Talk To A Speech Clinician
  • Unmoderated Discussion
    • Open Forum
    • Newly Diagnosed
    • Caregivers Forum
    • Young Onset Forum
    • DBS Forum

Found 1 result

  1. http://edition.cnn.com/2016/08/31/health/experimental-alzheimers-drug/index.html The Alzheimer's community is also holding its collective breath about aducanumab from Biogen which is demonstrating plaque clearing in Alzheimer's brains. The plaque in Alzheimer's brains is a different protein-beta amyloid-which is also destroying the brain neurons as they collectively spread throughout the brain. Alzheimer's starts in the hippocampus which is the short term memory and spatial part of the brain in which immediate and daily memory is stored until it moves into long term memory after a good night's sleep. The damage in the hippocampus is why Alzheimer's patients continually repeat their statements, questions, etc. over and over. They can't remember that they already asked the question, etc. Anyway, aducanumab may be the answers to those prayers for Alzheimer's patients-this research is conducted on patients instead of mice so the hope is enticingly close. Alzheimer's affects about 5 to 6 million Americans and this is the most hopeful news so far. The Parkinson's and Alzheimer's communities might have good news over the next few years-we can only hold our breath and hope!!
×